These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8480981)

  • 21. Left ventricular function after late thrombolysis with alteplase in myocardial infarction.
    Gil VM; Ventosa A; Antunes AF; Morais J; Seabra-Gomes R
    Rev Port Cardiol; 1996 May; 15(5):413-20, 366. PubMed ID: 8763515
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of metabolic syndrome on coronary patency after thrombolytic therapy for acute myocardial infarction.
    Yasar AS; Bilen E; Bilge M; Arslantas U; Karakas F
    Coron Artery Dis; 2009 Sep; 20(6):387-91. PubMed ID: 19696662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bilateral renal embolism during thrombolytic therapy with tissue-type plasminogen activator in a patient with thrombosis of the left ventricle].
    Abassade P; Iung B; Baudouy PY; Vuong PN; Valleteau de Moulliac M
    Arch Mal Coeur Vaiss; 1991 Apr; 84(4):583-5. PubMed ID: 1905916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolysis utilisation in acute myocardial infarction in Bahrain.
    Chawla AK; Nambiar CA; Murad AA
    Indian Heart J; 1996; 48(2):155-8. PubMed ID: 8682556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The early risk of thrombolytic therapy for acute myocardial infarction: incidence, mechanisms and possible prevention.
    Verheugt FW
    J Cardiovasc Risk; 1998 Apr; 5(2):103-8. PubMed ID: 9821063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of recent myocardial infarction during menstruation--presentation of a case].
    Puzio B; Poloński L; Kuśnierz B
    Kardiol Pol; 1993 Aug; 39(8):113-4. PubMed ID: 8231006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy].
    Kobusiak-Prokopowicz M; Mysiak A
    Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intracerebral hemorrhage after thrombolytic therapy managed with ventricular drainage.
    Al-Khawaja D; Eslick GD; Fuller SJ; Seex K
    J Clin Neurosci; 2007 Sep; 14(9):898-900. PubMed ID: 17660059
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac tamponade mimicking ventricular rupture after thrombolysis for acute myocardial infarction.
    Imperadore F; Spagnolli W; Martinelli L; Musuraca G; De Girolamo P; Maines M; Vergara G
    Minerva Cardioangiol; 2003 Aug; 51(4):417-8. PubMed ID: 12900724
    [No Abstract]   [Full Text] [Related]  

  • 30. Cerebral venous congestion as indication for thrombolytic treatment.
    Tsai FY; Kostanian V; Rivera M; Lee KW; Chen CC; Nguyen TH
    Cardiovasc Intervent Radiol; 2007; 30(4):675-87. PubMed ID: 17573553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma TAFI and soluble CD40 ligand do not predict reperfusion following thrombolysis for acute myocardial infarction.
    Cruden NL; Graham C; Harding SA; Ludlam CA; Fox KA; Newby DE
    Thromb Res; 2006; 118(2):189-97. PubMed ID: 16055173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombolytic therapy for myocardial infarction in oral anticoagulation].
    Pizzulli L; Lüderitz B
    Dtsch Med Wochenschr; 1996 Mar; 121(13):424. PubMed ID: 8681737
    [No Abstract]   [Full Text] [Related]  

  • 33. [Repeat thrombolysis in acute myocardial infarction].
    Sychra M
    Vnitr Lek; 2002 Aug; 48(8):791-3. PubMed ID: 12425212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 35. Fatal intracerebral hemorrhage following thrombolytic therapy of embolic myocardial infarction in unsuspected infective endocarditis.
    Di Salvo TG; Tatter SB; O'Gara PT; Nielsen GP; DeSanctis RW
    Clin Cardiol; 1994 Jun; 17(6):340-4. PubMed ID: 8070153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Regional fibrinolysis with tissue plasminogen activator (rt-PA) (Actilyse)].
    Toft P; Heslet L; Nielsen L
    Ugeskr Laeger; 1990 Oct; 152(44):3271-3. PubMed ID: 2122568
    [No Abstract]   [Full Text] [Related]  

  • 37. [Cerebral embolism as a complication. Incidence and pathogenesis after heart infarct].
    Donhuijsen-Ant R; Peitsch U; Holldack K
    Fortschr Med; 1976 Mar; 94(7):349-53. PubMed ID: 964890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Embolic cerebral infarction and gastrointestinal hemorrhage following thrombolytic therapy for acute myocardial infarction.
    Chang MC; Lee AY; Chang WF; Chen TJ
    Echocardiography; 2002 Feb; 19(2):139-41. PubMed ID: 11926976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Thrombolytic therapy. I. Introduction and principles of therapy. Indications. Contraindications. Schematics of the treatment].
    Sterkowicz S
    Przegl Lek; 1969; 25(8):565-8. PubMed ID: 4897431
    [No Abstract]   [Full Text] [Related]  

  • 40. Embolic stroke following thrombolytic therapy for myocardial infarction in a patient with preexisting ventricular thrombi.
    Bautista RE
    Stroke; 1995 Feb; 26(2):324-5. PubMed ID: 7831707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.